These findings demonstrated that TRPV4 is functional in mouse CFs and directly related to the fibrosis process insofar as its genetic deletion preserves cardiac function and protects the heart against adverse fibrosis effects [168]. This evidence concerns the gene TRPV4 and myalgic encephalomeyelitis/chronic fatigue syndrome.